argenx SE | ARGX - Cash And Equivalent

Stock Price
717.60
Daily Change
-1.00 -0.14%
Monthly
4.97%
Yearly
11.92%
Q1 Forecast
686.63

argenx SE reported $4.3B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AstraZeneca USD 8.14B 1.08B Sep/2025
Galapagos EUR 64.46M 43.61M Sep/2025
Genmab DKK 1.3B 323M Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
UCB EUR 1.57B 1.14B Dec/2024